Obesity, M&A, Biotech Resurgence: A 2026 Guide to Health Stocks
Published on January 8, 2026
The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is changing.